Journal of Manipulative and Physiological Therapeutics
Volume 27, Issue 9 , Pages 591-595 , November 2004

Health Care For Our Bones: A Practical Nutritional Approach to Preventing Osteoporosis

  • David Seaman, DC

      Affiliations

    • Corresponding Author InformationDavid Seaman, DC, Palmer 477 City Center Pkwy, Port Orange, FL 32129.

Received 4 August 2003 ,Revised 19 August 2003

References 

  1. Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women. Results from the national osteoporosis risk assessment. J Am Med Assoc. 2001;286:2815–2822
  2. Hegsted DM. Fractures, calcium and the modern diet. Am J Clin Nutr. 2001;74:571–573
  3. Watkins BA, Lippman HE, Le Bouteiller L, Li Y, Seifert MF. Bioactive fatty acids: role in bone biology and bone cell function. Prog Lip Res. 2001;40:125–148
  4. Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PW, Kiel DP. Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr. 1999;69:727–736
  5. New SA, Robins SP, Campbell MK, Martin JC, Garton MJ, Bolton-Smith C, et al. Dietary influences on bone mass and bone metabolism: further evidence of a positive link between fruit and vegetable consumption and bone health?. Am J Clin Nutr. 2000;71:142–151
  6. Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris RC. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med. 1994;330:1776–1781
  7. Remer T. Influence of diet on acid-base balance. Semin Dial. 2000;13:221–226
  8. Lindh E, Ljunghall S, Larsson K, Lavo B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med. 1992;231:403–406
  9. Cordain L. Cereal grains: humanity's double edge sword. World Rev Nutr Diet. 1999;84:19–73
  10. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70(Suppl):560S–569S
  11. Simopoulos AP. In: The omega diet. New York, NY: HarperCollins; 1999;p. 124–131
  12. Seaman DR. In: Clinical nutrition for pain, inflammation, and tissue healing. Hendersonville, NC: NutrAnalysis; 1998;p. 107–109
  13. Hands ES. In: Nutrients in food. Philadelphia, PA: Lippincott Williams & Wilkins; 2000;p. 1–336
  14. Heaney RP. Protein intake and bone health: the influence of belief systems on the conduct of nutritional science. Am J Clin Nutr. 2001;73:5–6
  15. Cordain L, Watkins BA, Florant GL, Kelher M, Rogers L, Li Y. Fatty acid analysis of wild ruminant tissues: evolutionary implications for reducing diet-related chronic disease. Eur J Clin Nutr. 2002;56:181–191
  16. Ilich JZ, Kerstetter JE. Nutrition in bone health revisted: a story beyond calcium. J Am Coll Nutr. 2000;19:715–737
  17. Roubenoff R, Blumberg JB. The effects of a multivitamin/mineral supplement on micronutrient status, antioxidant capacity and cytokine production in healthy older adults consuming a fortified diet. J Am Coll Nutr. 2000;19:613–621
  18. McKay DL, Perrone G, Rasmussen H, Dallal G, Blumberg JB. Multivitamin/mineral supplementation improves plasma B-vitamin status and homocysteine concentration in healthy older adults consuming a folate-fortified diet. J Nutr. 2000;130:3090–3096
  19. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition. 2001;17:709–712
  20. Mares-Perlman JA, Lyle BJ, Klein R, Fishre AL, Brady WE, VandenLangenberg GM, et al. Vitamin supplement use and incident cataracts in a population-based study. Arch Ophthalmol. 2000;118:1556–1563
  21. Schlebusch L, Bosch BA, Polglase G, Kleinschmidt I, Pillay BJ, Cassimjee MH. A double-blind, placebo-controlled, double-centre study of the effects of an oral multivitamin-mineral combination on stress. S Afr Med J. 2000;90:1216–1223
  22. Fenech M, Ferguson LR. Vitamins/minerals and genomic stability in humans. Mutat Res. 2001;475:1–6
  23. Frank E, Bendich A, Denniston M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr. 2000;72:969–975
  24. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495–505
  25. Kremer JM. N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2000;71(1 Suppl):349S–351S
  26. Elin RJ. Magnesium: fifth but forgotten electrolyte. Am J Clin Path. 1994;102:616–622
  27. Alexandersen P, Riis B. Letters to editor. J Am Med Assoc. 2001;286:1836–1837
  28. Dreosti IE. Magnesium status and health. Nutr Rev. 1995;53(Suppl):S23–S27
  29. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am J Cardiol. 1989;63:4G–21G
  30. Durlach J. Recommended dietary amounts of magnesium: Mg RDA. Mag Res. 1989;2:195–203
  31. Brandi ML. Flavonoids: biochemical effects and therapeutic applications. Bone Mineral. 1992;19(Suppl):S3–S14
  32. Agnusdei D, Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int. 1997;61(Suppl):S23–S32
  33. Scheiber MD, Rebar RW. Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?. Menopause. 1999;6:233–241
  34. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. J Am Med Assoc. 2001;285:1482–1488
  35. Beers MN, Berkow R. In: The merck manual of diagnosis and therapy. 17th Ed. Whitehouse Station, NJ: Merck Research Laboratories; 1999;p. 854
  36. Pines A, Raafat H, Lynn AH, Whittington J. Clinical trial of microcrystalline hydroxyapatite compound (‘Ossopan’) in the prevention of osteoporosis due to corticosteroid therapy. Curr Med Res Opin. 1984;8:734–742
  37. Stellon A, Davies A, Webb A, Williams R. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis. Postgrad Med J. 1985;61:791–796
  38. Ruegsegger P, Keller A, Dambacher MA. Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporosis Int. 1995;5:30–34

PII: S0161-4754(04)00241-6

doi: 10.1016/j.jmpt.2004.10.009

Journal of Manipulative and Physiological Therapeutics
Volume 27, Issue 9 , Pages 591-595 , November 2004

Article Tools